Sanofi, Canadian Drug Alliance Reach Sarclisa Funding Deal for Multiple Myeloma Patients
MT newswire2026/11/16 14:28Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
10:28 AM EST, 11/16/2026 (MT Newswires) -- Sanofi (SNY) and the pan-Canadian Pharmaceutical Alliance signed a letter of intent for the pharmaceutical company's Sarclisa, paving the way for public drug-plan coverage of the therapy for newly diagnosed, transplant-ineligible multiple myeloma patients in Canada. Sarclisa, used with standard therapy as a first-line treatment, showed 63% of patients were progression-free after five years versus 45% on standard therapy alone and reduced the risk of disease progression or death by 40%, Sanofi said Monday in a statement. Price: 48.76, Change: +0.39, Percent Change: +0.81
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
'Grand Theft Auto VI' Drives Comcast, Charter to Record Traffic
MT newswire•2026/11/20 22:22
Crypto prices
MoreBitcoin
BTC
$58,986.3
-4.89%
Ethereum
ETH
$1,623.25
-7.35%
Tether USDt
USDT
$0.9977
-0.12%
BNB
BNB
$539.19
-7.09%
USDC
USDC
$1.0000
+0.00%
XRP
XRP
$0.9089
-5.35%
Solana
SOL
$68.89
-5.35%
TRON
TRX
$0.3013
-2.88%
Hyperliquid
HYPE
$60.61
-8.64%
Zcash
ZEC
$753.34
-15.02%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now